Imago BioSciences Seeks $105 Million IPO

Andrew Brookes/Cultura via Getty Images
Quick Take
Imago BioSciences (IMGO) has filed to raise $105 million in an IPO of its common stock, according to an S-1/A registration statement.
The firm is a clinical stage biopharma developing treatments for bone…

Click here to view the original article.